Shivam Chemicals Limited has commenced Phase I production of Feed-Grade Dicalcium Phosphate (DCP) at its subsidiary’s manufacturing unit in Dahej, Gujarat. This move adds in-house manufacturing capabilities to the group's existing distribution network.

The production is undertaken by the wholly owned subsidiary, Shivam Chemicals & Minerals Private Limited. The initiative strategically expands the company's established presence in the feed phosphate business by integrating manufacturing with its current sales and distribution platform.

Integration with existing operations

The new DCP capability complements the group's existing Hydrated Lime manufacturing operations. These operations have an installed production capacity of approximately 5,000 MT per month. Dicalcium Phosphate serves as a critical source of phosphorus and calcium for animal nutrition and feed formulations.

By bringing DCP production in-house, the company aims to progressively strengthen its participation across the entire feed phosphate value chain. This development aligns with the broader corporate strategy of strengthening existing businesses through manufacturing integration and broadening the product portfolio.

Strategic expansion and future outlook

The Dahej facility represents Phase I of a planned development for the feed phosphate manufacturing business. It establishes a platform for further expansion in this segment. The company intends to increase its presence in value-added products through this vertical integration.

The company stated that it will keep stakeholders informed of further material developments regarding the expansion of its feed phosphate manufacturing business. These updates will be communicated in accordance with applicable regulatory requirements.

Shivam Chemicals Limited has closed its trading window for dealing in company shares starting October 1, 2026. The restriction remains in effect until 48 hours after the Board of Directors approves the unaudited standalone and consolidated financial results for the half year ended September 30, 2026.

This action is taken pursuant to Clause 4 of Schedule B of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The closure applies to all insiders and designated employees of the company. The specific date for the Board Meeting to consider and approve these financial results will be intimated in due course.

Regulatory compliance details

The company filed this intimation with the Department of Corporate Services at BSE Limited on September 28, 2026. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sanjiv Vasant, Managing Director, signed the document digitally on September 28, 2026.